.jpg)
CONTINUING PHARMACY EDUCATION
Specialty, Oncology, and ID Drugs: What is in the Pipeline? - The 2025 Update (pharmacists and technicians)
Speaker:
SPEAKER: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services, (Continuum of Care Division), Premier Inc, Charlotte, NC
ACPE Universal Program ID# 0122-0000-25-071-H01-P/T
1 Contact Hours [0.1 CEU]
Release Date: September 22, 2025
Expiration Date: March 31, 2026
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
There are 2 steps to completing this home-study CE.
Step 1: Watch the video presentation in its entirety.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Describe growth trends of specialty/oncology agents in the pharmaceutical pipeline
- Identify notable agents that have been recently approved, are in the late stages of development, or are under regulatory review for infectious diseases indications
- Identify specialty drugs that are currently under regulatory review for select indications
- List oral oncology agents that are currently under regulatory review for various cancers
- Recognize parenteral oncology agents that are currently under regulatory review for various cancers
Speaker(s)/Author(s)
|
Liya Davydov, PharmD, BCPS, BCGP
|
Activity Number
0122-0000-25-071-H01-P/T
Release Date:
Sep 22, 2025
Credit Expiration Date:
Mar 31, 2026
CE Hours
1.00